Ocuphire Pharma Net Income 2010-2024 | IRD
Ocuphire Pharma net income from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Ocuphire Pharma Annual Net Income (Millions of US $) |
2023 |
$-10 |
2022 |
$18 |
2021 |
$-57 |
2020 |
$-25 |
2019 |
$-6 |
2018 |
$-14 |
2017 |
$-25 |
2016 |
$-9 |
2015 |
$-14 |
2014 |
$-19 |
2013 |
$-9 |
2012 |
$-6 |
2011 |
$-11 |
2010 |
$-14 |
2009 |
$-3 |
Ocuphire Pharma Quarterly Net Income (Millions of US $) |
2024-06-30 |
$-8 |
2024-03-31 |
$-7 |
2023-12-31 |
$-5 |
2023-09-30 |
$6 |
2023-06-30 |
$-5 |
2023-03-31 |
$-6 |
2022-12-31 |
$34 |
2022-09-30 |
$-5 |
2022-06-30 |
$-5 |
2022-03-31 |
$-7 |
2021-12-31 |
$-6 |
2021-09-30 |
$-4 |
2021-06-30 |
$-7 |
2021-03-31 |
$-39 |
2020-12-31 |
$-19 |
2020-09-30 |
$-1 |
2020-06-30 |
$-2 |
2020-03-31 |
$-3 |
2019-12-31 |
$1 |
2019-09-30 |
$-2 |
2019-06-30 |
$-2 |
2019-03-31 |
$-2 |
2018-12-31 |
$-3 |
2018-09-30 |
$-5 |
2018-06-30 |
$-4 |
2018-03-31 |
$-2 |
2017-12-31 |
$-4 |
2017-09-30 |
$-1 |
2017-06-30 |
$1 |
2017-03-31 |
$-22 |
2016-12-31 |
$-1 |
2016-09-30 |
$-3 |
2016-06-30 |
$-2 |
2016-03-31 |
$-4 |
2015-12-31 |
$-3 |
2015-09-30 |
$-4 |
2015-06-30 |
$-3 |
2015-03-31 |
$-4 |
2014-12-31 |
$-2 |
2014-09-30 |
$-2 |
2014-06-30 |
$0 |
2014-03-31 |
$-15 |
2013-12-31 |
$-3 |
2013-09-30 |
$-2 |
2013-06-30 |
$-3 |
2013-03-31 |
$-2 |
2012-12-31 |
$-0 |
2012-09-30 |
$-3 |
2012-06-30 |
$-1 |
2012-03-31 |
$-2 |
2011-12-31 |
$0 |
2011-09-30 |
$-1 |
2011-06-30 |
$-6 |
2011-03-31 |
$-4 |
2010-12-31 |
$-3 |
2010-09-30 |
$0 |
2010-06-30 |
$-4 |
2010-03-31 |
$-8 |
2009-12-31 |
$2 |
2009-09-30 |
$-1 |
2009-06-30 |
$-2 |
2009-03-31 |
$-1 |
Sector |
Industry |
Market Cap |
Revenue |
|
|
$0.000B |
$0.000B |
Ocuphire Pharma Inc. is a clinical-stage ophthalmic biopharmaceutical company. It is focused on developing and commercializing therapies for the treatment of several eye disorders. The company's product pipeline includes Nyxol Eye Drops(R) and APX3330. Ocuphire Pharma Inc., formerly known as Rexahn Pharmaceuticals Inc., is based in FARMINGTON HILLS, Mich.
|